Long-term effects of fingolimod in multiple sclerosis: The randomized FREEDOMS extension trial

OBJECTIVE: To assess long-term safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (RRMS). METHODS: Patients completing FTY720 Research Evaluating Effects of Daily Oral Therapy in MS (FREEDOMS) were eligible for this dose-blinded, parallel-group extension study,...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Neurology
Egile Nagusiak: Kappos, Ludwig, O'Connor, Paul, Radue, Ernst-Wilhelm, Polman, Chris, Hohlfeld, Reinhard, Selmaj, Krzysztof, Ritter, Shannon, Schlosshauer, Rolf, von Rosenstiel, Philipp, Zhang-Auberson, Lixin, Francis, Gordon
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Lippincott Williams & Wilkins 2015
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4408283/
https://ncbi.nlm.nih.gov/pubmed/25795646
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000001462
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak